7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
A clinical guide to Leqvio (inclisiran) subcutaneous injection for patients 65+, covering caregiver technique, storage, missed-dose rules, and safety monitoring in older adults.
A guide to inclisiran use in adults 65 and older, covering physical activity safety, cardiac rehabilitation, fall risk, injection scheduling, and how older patients can maintain active lives while on twice-yearly PCSK9 inhibitor therapy.
A comprehensive clinical guide to how inclisiran (Leqvio) affects growth, puberty, hormones, and long-term development in adolescents ages 12 to 17 with heterozygous familial hypercholesterolemia.
Current evidence and FDA labeling for Leqvio (inclisiran) in adolescents ages 12 to 17 with familial hypercholesterolemia, including dosing, administration, safety, and remaining off-label uses.
A guide to inclisiran (Leqvio) use in patients aged 65 and older, covering trial evidence, safety data, renal and hepatic considerations, and clinical decision-making for geriatric ASCVD management.
How adolescents aged 12 to 17 taking inclisiran (Leqvio) for heterozygous familial hypercholesterolemia should transition to adult lipid care, including dosing continuity, monitoring schedules, and shared decision-making frameworks.
Complete caregiver guide to administering Leqvio (inclisiran) to adolescents aged 12-17 with HeFH: injection technique, dosing schedule, storage, side-effect management, and when to call the clinic.